Literature DB >> 2527255

In vivo handling of soluble complement fixing Ab/dsDNA immune complexes in chimpanzees.

R P Kimberly1, J C Edberg, L T Merriam, S B Clarkson, J C Unkeless, R P Taylor.   

Abstract

We used soluble, C-fixing antibody/dsDNA IC to investigate immune complex (IC) handling and erythrocyte (E)-to-phagocyte transfer in chimpanzees. IC bound efficiently to chimpanzee E in vitro and showed minimal release with further in vitro incubation in the presence of serum in EDTA (less than or equal to 15% within 1 h). These IC also bound rapidly to E in vivo (70-80% binding within 1 min) and did not show detectable release from E in the peripheral circulation after infusion in vivo (less than or equal to 2% within 1 h). Despite such slow C-mediated release of IC from E, IC were rapidly stripped from E by the mononuclear phagocyte system (T50 for E-IC1500 = 5 min) without sequestration of E. Treatment of the chimpanzees with the anti-Fc gamma RIII MAb 3G8 impaired the clearance of infused IC. This effect was most evident on the fraction of IC500 which did not bind to E and which presumably had captured less C3b (pre-MAb 3G8 T50: 45 min vs. post-MAb 3G8 T50: 180 min). With IC bound in vitro to E before infusion, anti-Fc gamma RIII MAb treatment led to significant amounts of non-E bound IC detectable in the circulation. Thus, the anti-Fc gamma RIII MAb appeared to interfere with the ability of fixed tissue mononuclear phagocytes to take up/or retain IC after their release from E. Both rapid stripping of IC from E, despite slow complement-mediated release of IC from E in the peripheral circulation, and blockade of IC clearance with anti-Fc gamma RIII MAb indicate that the interaction of IC with the fixed tissue phagocyte involves qualitatively different mechanisms than the interaction of IC with E. Fc gamma receptors appear to play an important role in the transfer and retention of IC by the phagocyte.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2527255      PMCID: PMC329742          DOI: 10.1172/JCI114259

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  57 in total

1.  The immune-adherence phenomenon; an immunologically specific reaction between microorganisms and erythrocytes leading to enhanced phagocytosis.

Authors:  R A NELSON
Journal:  Science       Date:  1953-12-18       Impact factor: 47.728

2.  The clearance of tetanus toxoid/anti-tetanus toxoid immune complexes from the circulation of humans. Complement- and erythrocyte complement receptor 1-dependent mechanisms.

Authors:  J A Schifferli; Y C Ng; J Estreicher; M J Walport
Journal:  J Immunol       Date:  1988-02-01       Impact factor: 5.422

3.  Modulation of human polymorphonuclear leukocyte IgG Fc receptors and Fc receptor-mediated functions by IFN-gamma and glucocorticoids.

Authors:  K C Petroni; L Shen; P M Guyre
Journal:  J Immunol       Date:  1988-05-15       Impact factor: 5.422

Review 4.  The role of complement and its receptor in the elimination of immune complexes.

Authors:  J A Schifferli; Y C Ng; D K Peters
Journal:  N Engl J Med       Date:  1986-08-21       Impact factor: 91.245

5.  Mononuclear phagocyte function in SLE. I. Bipartite Fc- and complement-dependent dysfunction.

Authors:  R P Kimberly; N L Meryhew; O A Runquist
Journal:  J Immunol       Date:  1986-07-01       Impact factor: 5.422

6.  Clearance of soluble aggregates of human immunoglobulin G in healthy volunteers and chimpanzees.

Authors:  S Lobatto; M R Daha; A A Voetman; J H Evers-Schouten; A A Van Es; E K Pauwels; L A Van Es
Journal:  Clin Exp Immunol       Date:  1987-07       Impact factor: 4.330

7.  Human monocytes and U937 cells bear two distinct Fc receptors for IgG.

Authors:  R J Looney; G N Abraham; C L Anderson
Journal:  J Immunol       Date:  1986-03-01       Impact factor: 5.422

8.  Kinetics and mechanisms for removal of circulating single-stranded DNA in mice.

Authors:  W Emlen; M Mannik
Journal:  J Exp Med       Date:  1978-03-01       Impact factor: 14.307

9.  Immune interferon induces the receptor for monomeric IgG1 on human monocytic and myeloid cells.

Authors:  B Perussia; E T Dayton; R Lazarus; V Fanning; G Trinchieri
Journal:  J Exp Med       Date:  1983-10-01       Impact factor: 14.307

10.  Isolation of the receptor for IgG from a human monocyte cell line (U937) and from human peripheral blood monocytes.

Authors:  C L Anderson
Journal:  J Exp Med       Date:  1982-12-01       Impact factor: 14.307

View more
  12 in total

1.  A novel polymorphism of FcgammaRIIIa (CD16) alters receptor function and predisposes to autoimmune disease.

Authors:  J Wu; J C Edberg; P B Redecha; V Bansal; P M Guyre; K Coleman; J E Salmon; R P Kimberly
Journal:  J Clin Invest       Date:  1997-09-01       Impact factor: 14.808

2.  Use of heteropolymeric monoclonal antibodies to attach antigens to the C3b receptor of human erythrocytes: a potential therapeutic treatment.

Authors:  R P Taylor; W M Sutherland; C J Reist; D J Webb; E L Wright; R H Labuguen
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-15       Impact factor: 11.205

3.  Immune complex processing in C1q-deficient mice.

Authors:  J T Nash; P R Taylor; M Botto; P J Norsworthy; K A Davies; M J Walport
Journal:  Clin Exp Immunol       Date:  2001-02       Impact factor: 4.330

4.  Complement-independent binding of microorganisms to primate erythrocytes in vitro by cross-linked monoclonal antibodies via complement receptor 1.

Authors:  J H Powers; B L Buster; C J Reist; E Martin; M Bridges; W M Sutherland; R P Taylor; W M Scheld
Journal:  Infect Immun       Date:  1995-04       Impact factor: 3.441

5.  Both Fcgamma and complement receptors mediate transfer of immune complexes from erythrocytes to human macrophages under physiological flow conditions in vitro.

Authors:  A L Hepburn; J C Mason; S Wang; C J Shepherd; O Florey; D O Haskard; K A Davies
Journal:  Clin Exp Immunol       Date:  2006-10       Impact factor: 4.330

Review 6.  Fc receptor-targeted therapies for the treatment of inflammation, cancer and beyond.

Authors:  P Mark Hogarth; Geoffrey A Pietersz
Journal:  Nat Rev Drug Discov       Date:  2012-03-30       Impact factor: 84.694

7.  Mechanism of transfer of immune complexes from red blood cell CR1 to monocytes.

Authors:  W Emlen; V Carl; G Burdick
Journal:  Clin Exp Immunol       Date:  1992-07       Impact factor: 4.330

8.  PspA and PspC minimize immune adherence and transfer of pneumococci from erythrocytes to macrophages through their effects on complement activation.

Authors:  Jie Li; David T Glover; Alexander J Szalai; Susan K Hollingshead; David E Briles
Journal:  Infect Immun       Date:  2007-10-08       Impact factor: 3.441

9.  Immune adherence and clearance of hepatitis B surface Ag/Ab complexes is abnormal in patients with systemic lupus erythematosus (SLE).

Authors:  N Madi; G Steiger; J Estreicher; J A Schifferli
Journal:  Clin Exp Immunol       Date:  1991-09       Impact factor: 4.330

10.  Immune complex processing in patients with systemic lupus erythematosus. In vivo imaging and clearance studies.

Authors:  K A Davies; A M Peters; H L Beynon; M J Walport
Journal:  J Clin Invest       Date:  1992-11       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.